Greg Holtz

In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)

Jeffery J. Anderson, Margaret Bradbury, Darlene R. Giracello et al. · European Journal of Pharmacology · 2003 · 136 citations

Biochemistry, Functional Selectivity, Medicine +11

[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

Jeffery J. Anderson, Sara Rao, Blake A. Rowe et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 107 citations · Full text

Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice

Bruce Lamb, Kimberly A. Bardel, Laura Shapiro Kulnane et al. · Nature Neuroscience · 1999 · 102 citations

Genetics, Amyloid Production, Genetic Engineering +4

Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897

Jeffery J. Anderson, Greg Holtz, Patricia Baskin et al. · Biochemical Pharmacology · 2005 · 93 citations

Molecular Pharmacology, Neurodegenerative Diseases, Alzheimer's Disease +8

Control of basal-level codon misreading in Escherichiacoli

Jack Parker, Greg Holtz · Biochemical and Biophysical Research Communications · 1984 · 19 citations

Biology, Basal-level Codon Misreading, Gene Structure +3